Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.

A newspaper article caused a big rise in oral minoxidil prescriptions for hair loss.

CTP-543 is generally safe for treating alopecia areata.

Certain medications, especially nervous system drugs, can cause insomnia, with risks varying by age and gender.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Most patients on this hepatitis C treatment experienced skin issues, especially hair loss.

Oral minipulse therapy effectively treated bullous lichen planus in a 35-year-old woman.

Certain factors like being female, having high cholesterol, using Medicaid, and previous non-biologic treatments increase the risk of multiple biologic failures in psoriasis patients.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Metoprolol, a blood pressure medication, was linked to reversible hair loss.

Generic Palbociclib is safe and tolerable for treating certain breast cancer types.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

Some birth control pills increase blood clot risk; use them for specific conditions only.

Careful management of blood thinners is crucial for lupus patients with APS.

New drug uses show promise but need more research.

GLP-1RA therapy may increase the risk of hair loss.

PEGylated thymosin β4 shows promise for treating heart attacks effectively.

Properly administered testosterone therapy is safe and effective but often not covered by insurance.

Both cyproterone acetate and spironolactone effectively reduce hair growth in women with hirsutism.

Different PCOS characteristics affect lipid profiles, increasing cardiovascular disease risk, so regular lipid screening is advised.

Evening primrose oil significantly improves hormone levels and reduces BMI and cholesterol in women with PCOS.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.